http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20100014408-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5ffa3f9d6b87e15e0a1551fb129b531 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 |
| filingDate | 2008-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63b926b97e55b8ca4890a518f6fc8930 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61a666b4c84cf155798374150f9eb2f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e27622fdc951584955d09e5649e14147 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19e16676a77164ad4ada4fe3e2fe845c |
| publicationDate | 2010-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20100014408-A |
| titleOfInvention | Use of a composition comprising formoterol and beclomethasone dipropionate to prevent and / or treat asthma disease |
| abstract | The present invention complements the maintenance of asthma and provides the use of a composition suitable for the manufacture of a medicament for the prevention and / or emergency treatment of acute episodes.n n n More particularly, the present invention provides for the manufacture of a medicament for use in the treatment of episodes of asthma aggravation, intermittent asthma and / or chronic asthma during maintenance of asthma with the same composition for relief of symptoms if necessary. Acceptable salts or solvates thereof or formoterol as solvates of such salts; And b) beclomethasone dipropionate.n n n In one embodiment, the present invention provides a) a medicament for the manufacture of a medicament for use in the prevention of aggravation of asthma, intermittent asthma and / or chronic episodes of asthma during maintenance of asthma with the same composition to alleviate the symptoms if necessary. Formoterol as a scientifically acceptable salt or solvate thereof or solvate of such salt; And b) beclomethasone dipropionate.n n n Use of this composition, if necessary, relates to use in one or more of the states described below:n n n i) worsening of the condition of asthma or acute asthma attacks when the patient is irregularly exposed to factors (ie pollen, viral infections, cold air, exercise, perfume or other factors that cause asthma attacks);n n n ii) in the case of intermittent asthma, that is to say from time to time (less than twice a week), short-term aggravation (hours to days), where night-time aggravation is no more than twice a monthn n n iii) episodes, that is, acute attacks of short duration of bronchial spasms in chronic asthma |
| priorityDate | 2007-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 94.